Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability

dc.contributor.authorChoi, Sungwoon
dc.contributor.authorKeys, Heather
dc.contributor.authorStaples, Richard J.
dc.contributor.authorYuan, Junying
dc.contributor.authorDegterev, Alexei
dc.contributor.authorCuny, Gregory D.
dc.date.accessioned2020-03-10T17:31:16Z
dc.date.available2020-03-10T17:31:16Z
dc.date.issued2013-09
dc.description.abstractNecroptosis is a regulated caspase-independent cell death pathway with morphological features resembling passive non-regulated necrosis. Several diverse structure classes of necroptosis inhibitors have been reported to date, including a series of 3,3a,4,5-tetrahydro-2H-benz[g]indazoles (referred to as the Nec-3 series) displaying potent activity in cellular assays. However, evaluation of the tricyclic necroptosis inhibitor’s stability in mouse liver microsomes indicated that they were rapidly degraded. A structure–activity relationship (SAR) study of this compound series revealed that increased liver microsomal stability could be accomplished by modification of the pendent phenyl ring and by introduction of a hydrophilic substituent (i.e., ?-hydroxyl) to the acetamide at the 2-position of the tricyclic ring without significantly compromising necroptosis inhibitory activity. Further increases in microsomal stability could be achieved by utilizing the 5,5-dioxo-3-phenyl-2,3,3a,4-tetrahydro-[1]benzothiopyrano[4,3-c]pyrazoles. However, in this case necroptosis inhibitory activity was not maintained. Overall, these results provide a strategy for generating potent and metabolically stable tricyclic necrostatin analogs (e.g., 33, LDN-193191) potentially suitable for in vivo studies.
dc.identifier.citationCopyright 2012 Bioorganic and Medicinal Chemistry Letters. This is a post-print version of a published paper that is available at: https://www.sciencedirect.com/science/article/pii/S0960894X1200858X. Recommended citation: Choi, Sungwoon, Heather Keys, Richard J. Staples, Junying Yuan, Alexei Degterev, and Gregory D. Cuny. "Optimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability." Bioorganic & medicinal chemistry letters 22, no. 17 (2012): 5685-5688. doi: 10.1016/j.bmcl.2012.06.098. This item has been deposited in accordance with publisher copyright and licensing terms and with the author's permission.
dc.identifier.urihttps://hdl.handle.net/10657/5946
dc.language.isoen_US
dc.publisherBioorganic and Medicinal Chemistry Letters
dc.subjectNec-3
dc.subjectNecroptosis
dc.subjectInhibitors
dc.subjectstructure-activity relationship
dc.subjectmicrosomal stability
dc.titleOptimization of tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal stability
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cuny_2013_OptimizationofTricyclicAM.pdf
Size:
970.26 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.69 KB
Format:
Plain Text
Description: